Clinical Trials Logo

Filter by:
NCT ID: NCT00809575 Active, not recruiting - Clinical trials for Myelodysplastic Syndromes

Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes

PROMYS
Start date: October 2, 2008
Phase:
Study type: Observational

RATIONALE: Gathering information about quality of life, fatigue, and other symptoms from patients with myelodysplastic syndromes may help doctors learn more about the disease and may help plan treatment. PURPOSE: This clinical trial is studying quality of life and symptoms in patients with newly diagnosed myelodysplastic syndromes.

NCT ID: NCT00808301 Active, not recruiting - Clinical trials for Clinical and Nutritional Safety.

Oat Products in the Treatment of Coeliac Disease in Children

Start date: January 2009
Phase: N/A
Study type: Interventional

In many Northern European countries oat-based products have been used in the dieto-therapy of coeliac disease for many years. The purpose of this study is to evaluate clinical tolerance and liking of gluten-free products containing oatmeal from a specific oat variety (not contaminated with gluten) in a sample of Italian celiac patients in pediatric age.

NCT ID: NCT00797251 Active, not recruiting - Clinical trials for Hepatocellular Carcinoma

Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression

Start date: September 2007
Phase: N/A
Study type: Observational

The use of intraoperative ultrasound (IOUS) allows us to perform new conservative hepatectomies. The investigators previously reported the systematic subsegmentectomy by IOUS-guided finger compression for segments 2-3, which is currently applied for patients with hepatocellular carcinoma (HCC)on cirrhosis. The investigators herein describe a novel technique, which consists in the systematic right posterior sectionectomy by IOUS-guided finger compression.

NCT ID: NCT00795613 Active, not recruiting - HODGKIN LYMPHOMA Clinical Trials

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

HD0607
Start date: June 2008
Phase: Phase 2
Study type: Interventional

The purpose of this multicenter clinical trial is to assess the clinical impact of dose intensification performed very early during treatment in a subset of poor prognosis, advanced-stage Hodgkin Lymphoma patients, defined as PET-positive after two courses of conventional adriamycin (doxorubicin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy.

NCT ID: NCT00791700 Active, not recruiting - Clinical trials for Human Immunodeficiency Virus

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

Start date: April 22, 2009
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to determine the pharmacokinetic properties (what the body does to maraviroc) and to determine a suitable dosing schedule of maraviroc in HIV-1 infected children and adolescents. This study will also determine whether maraviroc is safe to use in children and adolescents.

NCT ID: NCT00780429 Active, not recruiting - Clinical trials for Kidney Transplantation

Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients

Start date: June 2006
Phase: N/A
Study type: Observational

Study of the pharmacokinetic and pharmacodynamic variability of mycophenolate mofetil in renal transplant patients already on long-term MMF treatment (at least 6 months post-transplant; at least 3 months in therapy). Study hypothesis: to investigate whether long-term MMF therapy alters IMPDH biological activity and if there are any correlations with the risk of AR.

NCT ID: NCT00777036 Active, not recruiting - Leukemia Clinical Trials

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Start date: March 20, 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether dasatinib is safe and effective in children and adolescents with newly diagnosed chronic myeloid leukemia (CML), or in children with Ph+ acute lymphoblastic leukemia (ALL), accelerated or blast phases CML who relapse after imatinib or who are resistant or intolerant to imatinib. The side effects of this oral investigational drug in children and adolescents will be evaluated

NCT ID: NCT00774826 Active, not recruiting - Follicular Lymphoma Clinical Trials

Multicentric Study, Three Randomized Arms (R−CVP vs R−CHOP vs R−FM),for Patients With Stage II−IV Follicular Lymphoma

Start date: December 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to define an improvement and theassessment of the Time to Treatment Failure in patients randomized in three different arms: R−CVP vs R−CHOP vs R−FM.

NCT ID: NCT00756509 Active, not recruiting - Clinical trials for Gastrointestinal Stromal Tumors

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

Start date: August 29, 2008
Phase: Phase 4
Study type: Interventional

The purpose of this multicenter, single-arm, exact binomial single-stage, phase II trial is to evaluate the efficacy of Nilotinib in patients with unresectable or metastatic gastrointestinal stromal tumors

NCT ID: NCT00751517 Active, not recruiting - Clinical trials for Microscopic Polyangiitis

Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides

Start date: n/a
Phase: Phase 2
Study type: Interventional

The Systemic Necrotizing Vasculitides (SNV) encompass a group of rare diseases which include Wegener's Granulomatosis (WG), Churg-Strauss Syndrome (CSS), Microscopic polyangiitis (MPA)and Polyarteritis nodosa (PAN). Common histological findings are inflammation with fibrinoid necrosis of the small vessels and sporadic or absent immune-deposits. The gold standard therapy for SNV is currently represented by the association of Cyclophosphamide and Prednisone. The limits of this approach are the high frequency of recurrent disease and an increased incidence of malignancy and infections. The aim of the present study is to compare the efficacy of Methotrexate vs Cyclophosphamide for Remission Maintenance in SNV.